Literature DB >> 11559641

Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study.

P Sutton1, S J Danon, M Walker, L J Thompson, J Wilson, T Kosaka, A Lee.   

Abstract

BACKGROUND AND AIMS: Helicobacter pylori is a major cause of peptic ulcers and gastric cancer. Vaccine development is progressing but there is concern that immunisation may exacerbate Helicobacter induced gastritis: prophylactic immunisation followed by challenge with H felis or H pylori can induce a more severe gastritis in mice than seen with infection alone. The aim of this study was to investigate the relationship between immunity to Helicobacter infection and post-immunisation gastritis.
METHODS: (1) C57BL/6 mice were prophylactically immunised before challenge with either H felis or H pylori. Histopathology and colonisation were assessed one month post-challenge. (2) C57BL/6 mice were prophylactically immunised against H felis infection and gastritis assessed up to 18 months post-challenge.
RESULTS: Prophylactic immunisation induced a reduction in bacterial colonisation following H felis challenge which was associated with increased severity of active gastritis with neutrophil infiltration and atrophy. However, immunised mice challenged with H pylori SS1 had little evidence of pathology. Long term follow up showed that post-immunisation gastritis was evident at three months. However, from six months onwards, although immunised/challenged mice still developed gastritis, there was no significant difference between inflammation in these mice and infected controls. Post-immunisation gastritis was not associated with the serum antibody response. Immunisation prevented the formation of secondary lymphoid aggregates in the gastric tissue.
CONCLUSION: The H felis mouse model of post-immunisation gastritis is the most extreme example of this type of pathology. We have shown in this model that post-immunisation gastritis is a transient event which does not produce long term exacerbation of pathology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559641      PMCID: PMC1728471          DOI: 10.1136/gut.49.4.467

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis model.

Authors:  M Chen; A Lee; S Hazell
Journal:  Lancet       Date:  1992-05-02       Impact factor: 79.321

2.  Urease-based mucosal immunization against Helicobacter heilmannii infection induces corpus atrophy in mice.

Authors:  C Dieterich; H Bouzourène; A L Blum; I E Corthésy-Theulaz
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Therapeutic immunisation against Helicobacter infection.

Authors:  C Doidge; I Crust; A Lee; F Buck; S Hazell; U Manne
Journal:  Lancet       Date:  1994-04-09       Impact factor: 79.321

Review 4.  NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease.

Authors: 
Journal:  JAMA       Date:  1994-07-06       Impact factor: 56.272

Review 5.  Gastric MALT lymphoma: from concept to cure.

Authors:  P G Isaacson
Journal:  Ann Oncol       Date:  1999-06       Impact factor: 32.976

6.  A small animal model of human Helicobacter pylori active chronic gastritis.

Authors:  A Lee; J G Fox; G Otto; J Murphy
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

7.  Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization.

Authors:  S J Czinn; A Cai; J G Nedrud
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

8.  Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease.

Authors:  P Michetti; I Corthésy-Theulaz; C Davin; R Haas; A C Vaney; M Heitz; J Bille; J P Kraehenbuhl; E Saraga; A L Blum
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

Review 9.  Mucosa-associated lymphoid tissue lymphoma.

Authors:  P G Isaacson
Journal:  Semin Hematol       Date:  1999-04       Impact factor: 3.851

10.  Immunisation against gastric infection with Helicobacter species: first step in the prophylaxis of gastric cancer?

Authors:  M Chen; A Lee; S Hazell; P Hu; Y Li
Journal:  Zentralbl Bakteriol       Date:  1993-09
View more
  23 in total

1.  Oral vaccination against Helicobacter pylori infection is not effective in mice with Fas ligand deficiency.

Authors:  Yaron Avitzur; Esther Galindo-Mata; Nicola L Jones
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  Inhibition of H. pylori colonization and prevention of gastritis in murine model.

Authors:  Mahdieh Ameri Shah Reza; Seyed Latif Mousavi Gargari; Iraj Rasooli; Mohammadreza Jalali Nadoushan; Walead Ebrahimizadeh
Journal:  World J Microbiol Biotechnol       Date:  2012-04-28       Impact factor: 3.312

3.  Protease-activated receptor 1 suppresses Helicobacter pylori gastritis via the inhibition of macrophage cytokine secretion and interferon regulatory factor 5.

Authors:  Y-T Chionh; G Z Ng; L Ong; A Arulmuruganar; A Stent; M A Saeed; J Lk Wee; P Sutton
Journal:  Mucosal Immunol       Date:  2014-05-28       Impact factor: 7.313

4.  Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach.

Authors:  Mai Ping Tan; Maria Kaparakis; Maja Galic; John Pedersen; Martin Pearse; Odilia L C Wijburg; Peter H Janssen; Richard A Strugnell
Journal:  Appl Environ Microbiol       Date:  2006-12-01       Impact factor: 4.792

5.  Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice.

Authors:  Lucinda J Thompson; Stephen J Danon; John E Wilson; Jani L O'Rourke; Nina R Salama; Stanley Falkow; Hazel Mitchell; Adrian Lee
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens.

Authors:  Yok-Teng Chionh; Janet L K Wee; Alison L Every; Garrett Z Ng; Philip Sutton
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

7.  CD8+ T cells are associated with severe gastritis in Helicobacter pylori-infected mice in the absence of CD4+ T cells.

Authors:  Mai Ping Tan; John Pedersen; Yifan Zhan; Andrew M Lew; Martin J Pearse; Odilia L C Wijburg; Richard A Strugnell
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

8.  Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations.

Authors:  Michael Vajdy; Manmohan Singh; Mildred Ugozzoli; Maylene Briones; Elawati Soenawan; Lina Cuadra; Jina Kazzaz; Paolo Ruggiero; Samuele Peppoloni; Francesco Norelli; Giuseppe del Giudice; Derek O'Hagan
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

9.  Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infection.

Authors:  S Raghavan; J Nyström; M Fredriksson; J Holmgren; A M Harandi
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis.

Authors:  S Raghavan; A-M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.